Recormon

epoetin beta · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recormon, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy [Phase 4]